In the cancer context, ADO—a direct product of ATP hydrolysis catalyzed by the sequential actions of CD39 and CD73 ecto-nucleotidases—elicits an immunosuppressive response by modulating the phenotype of tumor-infiltrated immune cells [83, 84]. The gene discussed is NT5E; the disease is neoplasm.